The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cold Chain for Pharmaceutical-Global Market Insights and Sales Trends 2024
Synopsis
The global Cold Chain for Pharmaceutical market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cold Chain for Pharmaceutical in various end use industries. The expanding demands from the Pharmaceuticals, Blood Goods and Other, are propelling Cold Chain for Pharmaceutical market. Refrigerated Storage, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cold Chain Logistics segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cold Chain for Pharmaceutical, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cold Chain for Pharmaceutical market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cold Chain for Pharmaceutical market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cold Chain for Pharmaceutical sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cold Chain for Pharmaceutical covered in this report include Deutsche Post, FedEx, Biotec Services, UPS, Nichirei Logistics Group, Air Canada Cargo, Helapet, Igloo Thermo-Logistics and Kerry Logistics, etc.
The global Cold Chain for Pharmaceutical market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Deutsche Post
FedEx
Biotec Services
UPS
Nichirei Logistics Group
Air Canada Cargo
Helapet
Igloo Thermo-Logistics
Kerry Logistics
XPO Logistics
Cold Chain Technologies
Continental Air Cargo
Lineage Logistics
OOCL Logistics
SCG Logistics
JWD Group
Swire Group
Burris Logistics
VersaCold Logistics Services
LifeConEx
Marken
Nordic Cold Storage
Panalpina World Transport
Sofrigam
Global Cold Chain for Pharmaceutical market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cold Chain for Pharmaceutical market, Segment by Type:
Refrigerated Storage
Cold Chain Logistics
Global Cold Chain for Pharmaceutical market, by Application
Pharmaceuticals
Blood Goods
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cold Chain for Pharmaceutical companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Cold Chain for Pharmaceutical market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cold Chain for Pharmaceutical in various end use industries. The expanding demands from the Pharmaceuticals, Blood Goods and Other, are propelling Cold Chain for Pharmaceutical market. Refrigerated Storage, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cold Chain Logistics segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cold Chain for Pharmaceutical, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cold Chain for Pharmaceutical market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cold Chain for Pharmaceutical market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cold Chain for Pharmaceutical sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cold Chain for Pharmaceutical covered in this report include Deutsche Post, FedEx, Biotec Services, UPS, Nichirei Logistics Group, Air Canada Cargo, Helapet, Igloo Thermo-Logistics and Kerry Logistics, etc.
The global Cold Chain for Pharmaceutical market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Deutsche Post
FedEx
Biotec Services
UPS
Nichirei Logistics Group
Air Canada Cargo
Helapet
Igloo Thermo-Logistics
Kerry Logistics
XPO Logistics
Cold Chain Technologies
Continental Air Cargo
Lineage Logistics
OOCL Logistics
SCG Logistics
JWD Group
Swire Group
Burris Logistics
VersaCold Logistics Services
LifeConEx
Marken
Nordic Cold Storage
Panalpina World Transport
Sofrigam
Global Cold Chain for Pharmaceutical market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cold Chain for Pharmaceutical market, Segment by Type:
Refrigerated Storage
Cold Chain Logistics
Global Cold Chain for Pharmaceutical market, by Application
Pharmaceuticals
Blood Goods
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cold Chain for Pharmaceutical companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Cold Chain for Pharmaceutical
1.1 Cold Chain for Pharmaceutical Market Overview
1.1.1 Cold Chain for Pharmaceutical Product Scope
1.1.2 Cold Chain for Pharmaceutical Market Status and Outlook
1.2 Global Cold Chain for Pharmaceutical Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cold Chain for Pharmaceutical Market Size by Region (2018-2029)
1.4 Global Cold Chain for Pharmaceutical Historic Market Size by Region (2018-2023)
1.5 Global Cold Chain for Pharmaceutical Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cold Chain for Pharmaceutical Market Size (2018-2029)
1.6.1 North America Cold Chain for Pharmaceutical Market Size (2018-2029)
1.6.2 Europe Cold Chain for Pharmaceutical Market Size (2018-2029)
1.6.3 Asia-Pacific Cold Chain for Pharmaceutical Market Size (2018-2029)
1.6.4 Latin America Cold Chain for Pharmaceutical Market Size (2018-2029)
1.6.5 Middle East & Africa Cold Chain for Pharmaceutical Market Size (2018-2029)
2 Cold Chain for Pharmaceutical Market by Type
2.1 Introduction
2.1.1 Refrigerated Storage
2.1.2 Cold Chain Logistics
2.2 Global Cold Chain for Pharmaceutical Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cold Chain for Pharmaceutical Historic Market Size by Type (2018-2023)
2.2.2 Global Cold Chain for Pharmaceutical Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cold Chain for Pharmaceutical Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cold Chain for Pharmaceutical Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cold Chain for Pharmaceutical Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cold Chain for Pharmaceutical Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cold Chain for Pharmaceutical Revenue Breakdown by Type (2018-2029)
3 Cold Chain for Pharmaceutical Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceuticals
3.1.2 Blood Goods
3.1.3 Other
3.2 Global Cold Chain for Pharmaceutical Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cold Chain for Pharmaceutical Historic Market Size by Application (2018-2023)
3.2.2 Global Cold Chain for Pharmaceutical Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cold Chain for Pharmaceutical Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cold Chain for Pharmaceutical Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cold Chain for Pharmaceutical Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cold Chain for Pharmaceutical Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cold Chain for Pharmaceutical Revenue Breakdown by Application (2018-2029)
4 Cold Chain for Pharmaceutical Competition Analysis by Players
4.1 Global Cold Chain for Pharmaceutical Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cold Chain for Pharmaceutical as of 2022)
4.3 Date of Key Players Enter into Cold Chain for Pharmaceutical Market
4.4 Global Top Players Cold Chain for Pharmaceutical Headquarters and Area Served
4.5 Key Players Cold Chain for Pharmaceutical Product Solution and Service
4.6 Competitive Status
4.6.1 Cold Chain for Pharmaceutical Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Deutsche Post
5.1.1 Deutsche Post Profile
5.1.2 Deutsche Post Main Business
5.1.3 Deutsche Post Cold Chain for Pharmaceutical Products, Services and Solutions
5.1.4 Deutsche Post Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.1.5 Deutsche Post Recent Developments
5.2 FedEx
5.2.1 FedEx Profile
5.2.2 FedEx Main Business
5.2.3 FedEx Cold Chain for Pharmaceutical Products, Services and Solutions
5.2.4 FedEx Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.2.5 FedEx Recent Developments
5.3 Biotec Services
5.3.1 Biotec Services Profile
5.3.2 Biotec Services Main Business
5.3.3 Biotec Services Cold Chain for Pharmaceutical Products, Services and Solutions
5.3.4 Biotec Services Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.3.5 UPS Recent Developments
5.4 UPS
5.4.1 UPS Profile
5.4.2 UPS Main Business
5.4.3 UPS Cold Chain for Pharmaceutical Products, Services and Solutions
5.4.4 UPS Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.4.5 UPS Recent Developments
5.5 Nichirei Logistics Group
5.5.1 Nichirei Logistics Group Profile
5.5.2 Nichirei Logistics Group Main Business
5.5.3 Nichirei Logistics Group Cold Chain for Pharmaceutical Products, Services and Solutions
5.5.4 Nichirei Logistics Group Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.5.5 Nichirei Logistics Group Recent Developments
5.6 Air Canada Cargo
5.6.1 Air Canada Cargo Profile
5.6.2 Air Canada Cargo Main Business
5.6.3 Air Canada Cargo Cold Chain for Pharmaceutical Products, Services and Solutions
5.6.4 Air Canada Cargo Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.6.5 Air Canada Cargo Recent Developments
5.7 Helapet
5.7.1 Helapet Profile
5.7.2 Helapet Main Business
5.7.3 Helapet Cold Chain for Pharmaceutical Products, Services and Solutions
5.7.4 Helapet Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.7.5 Helapet Recent Developments
5.8 Igloo Thermo-Logistics
5.8.1 Igloo Thermo-Logistics Profile
5.8.2 Igloo Thermo-Logistics Main Business
5.8.3 Igloo Thermo-Logistics Cold Chain for Pharmaceutical Products, Services and Solutions
5.8.4 Igloo Thermo-Logistics Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.8.5 Igloo Thermo-Logistics Recent Developments
5.9 Kerry Logistics
5.9.1 Kerry Logistics Profile
5.9.2 Kerry Logistics Main Business
5.9.3 Kerry Logistics Cold Chain for Pharmaceutical Products, Services and Solutions
5.9.4 Kerry Logistics Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.9.5 Kerry Logistics Recent Developments
5.10 XPO Logistics
5.10.1 XPO Logistics Profile
5.10.2 XPO Logistics Main Business
5.10.3 XPO Logistics Cold Chain for Pharmaceutical Products, Services and Solutions
5.10.4 XPO Logistics Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.10.5 XPO Logistics Recent Developments
5.11 Cold Chain Technologies
5.11.1 Cold Chain Technologies Profile
5.11.2 Cold Chain Technologies Main Business
5.11.3 Cold Chain Technologies Cold Chain for Pharmaceutical Products, Services and Solutions
5.11.4 Cold Chain Technologies Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.11.5 Cold Chain Technologies Recent Developments
5.12 Continental Air Cargo
5.12.1 Continental Air Cargo Profile
5.12.2 Continental Air Cargo Main Business
5.12.3 Continental Air Cargo Cold Chain for Pharmaceutical Products, Services and Solutions
5.12.4 Continental Air Cargo Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.12.5 Continental Air Cargo Recent Developments
5.13 Lineage Logistics
5.13.1 Lineage Logistics Profile
5.13.2 Lineage Logistics Main Business
5.13.3 Lineage Logistics Cold Chain for Pharmaceutical Products, Services and Solutions
5.13.4 Lineage Logistics Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.13.5 Lineage Logistics Recent Developments
5.14 OOCL Logistics
5.14.1 OOCL Logistics Profile
5.14.2 OOCL Logistics Main Business
5.14.3 OOCL Logistics Cold Chain for Pharmaceutical Products, Services and Solutions
5.14.4 OOCL Logistics Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.14.5 OOCL Logistics Recent Developments
5.15 SCG Logistics
5.15.1 SCG Logistics Profile
5.15.2 SCG Logistics Main Business
5.15.3 SCG Logistics Cold Chain for Pharmaceutical Products, Services and Solutions
5.15.4 SCG Logistics Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.15.5 SCG Logistics Recent Developments
5.16 JWD Group
5.16.1 JWD Group Profile
5.16.2 JWD Group Main Business
5.16.3 JWD Group Cold Chain for Pharmaceutical Products, Services and Solutions
5.16.4 JWD Group Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.16.5 JWD Group Recent Developments
5.17 Swire Group
5.17.1 Swire Group Profile
5.17.2 Swire Group Main Business
5.17.3 Swire Group Cold Chain for Pharmaceutical Products, Services and Solutions
5.17.4 Swire Group Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.17.5 Swire Group Recent Developments
5.18 Burris Logistics
5.18.1 Burris Logistics Profile
5.18.2 Burris Logistics Main Business
5.18.3 Burris Logistics Cold Chain for Pharmaceutical Products, Services and Solutions
5.18.4 Burris Logistics Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.18.5 Burris Logistics Recent Developments
5.19 VersaCold Logistics Services
5.19.1 VersaCold Logistics Services Profile
5.19.2 VersaCold Logistics Services Main Business
5.19.3 VersaCold Logistics Services Cold Chain for Pharmaceutical Products, Services and Solutions
5.19.4 VersaCold Logistics Services Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.19.5 VersaCold Logistics Services Recent Developments
5.20 LifeConEx
5.20.1 LifeConEx Profile
5.20.2 LifeConEx Main Business
5.20.3 LifeConEx Cold Chain for Pharmaceutical Products, Services and Solutions
5.20.4 LifeConEx Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.20.5 LifeConEx Recent Developments
5.21 Marken
5.21.1 Marken Profile
5.21.2 Marken Main Business
5.21.3 Marken Cold Chain for Pharmaceutical Products, Services and Solutions
5.21.4 Marken Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.21.5 Marken Recent Developments
5.22 Nordic Cold Storage
5.22.1 Nordic Cold Storage Profile
5.22.2 Nordic Cold Storage Main Business
5.22.3 Nordic Cold Storage Cold Chain for Pharmaceutical Products, Services and Solutions
5.22.4 Nordic Cold Storage Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.22.5 Nordic Cold Storage Recent Developments
5.23 Panalpina World Transport
5.23.1 Panalpina World Transport Profile
5.23.2 Panalpina World Transport Main Business
5.23.3 Panalpina World Transport Cold Chain for Pharmaceutical Products, Services and Solutions
5.23.4 Panalpina World Transport Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.23.5 Panalpina World Transport Recent Developments
5.24 Sofrigam
5.24.1 Sofrigam Profile
5.24.2 Sofrigam Main Business
5.24.3 Sofrigam Cold Chain for Pharmaceutical Products, Services and Solutions
5.24.4 Sofrigam Cold Chain for Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.24.5 Sofrigam Recent Developments
6 North America
6.1 North America Cold Chain for Pharmaceutical Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cold Chain for Pharmaceutical Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cold Chain for Pharmaceutical Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cold Chain for Pharmaceutical Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cold Chain for Pharmaceutical Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cold Chain for Pharmaceutical Market Dynamics
11.1 Cold Chain for Pharmaceutical Industry Trends
11.2 Cold Chain for Pharmaceutical Market Drivers
11.3 Cold Chain for Pharmaceutical Market Challenges
11.4 Cold Chain for Pharmaceutical Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
